Immunome (IMNM) Asset Utilization Ratio (2023 - 2026)

Immunome's (IMNM) quarterly Asset Utilization Ratio came in at 0.01 in Q1 2026, down 83.58% YoY from 0.04 in Q1 2025, and down 56.38% on a QoQ basis from 0.01 in Q4 2025.

Immunome (IMNM) Asset Utilization Ratio (2023 - 2026) Analysis & Trends

Immunome (IMNM) has 4 years of Asset Utilization Ratio data on file, last reported at 0.01 in Q1 2026.

  • Quarterly Asset Utilization Ratio fell 83.58% year-over-year to 0.01 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.01 (down 83.58% YoY) and the FY2025 annual result came in at 0.02, down 67.68% from the prior year.
  • Asset Utilization Ratio fell to 0.01 in Q1 2026, from 0.01 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.12 in Q4 2023 to a low of 0.01 in Q1 2026.
  • A 4-year average of 0.04 and a median of 0.04 in 2024 frame the typical range for Asset Utilization Ratio.
  • Annual changes were most pronounced in 2025 — Asset Utilization Ratio grew 12.53% — and 2026, when it plunged 83.58%.
  • Tracing IMNM's Asset Utilization Ratio over 4 years: stood at 0.12 in 2023, then slumped by 68.64% to 0.04 in 2024, then sank by 61.16% to 0.01 in 2025, then plunged by 56.38% to 0.01 in 2026.
  • The last three Asset Utilization Ratio figures came in at 0.01 (Q1 2026), 0.01 (Q4 2025), and 0.03 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 0.47
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 0.38
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 0.69
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 186.67
7 Royalty Pharma 33.72 Bn 35.84 Bn - 0.13
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 0.90
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 0.54
10 Immunome 3.09 Bn 2.57 Bn - -

Historic Data

Download Data
DateValue
Mar 31, 2026 0.01
Dec 31, 2025 0.01
Sep 30, 2025 0.03
Jun 30, 2025 0.04
Mar 31, 2025 0.04
Dec 31, 2024 0.04
Sep 30, 2024 0.04
Jun 30, 2024 0.04
Mar 31, 2024 0.05
Dec 31, 2023 0.12